Nifty

:

20133.15

Sensex

:

66988.44

36.55 (0.18%)
86.53 (0.13%)

Login

Nifty
Sensex

:
:

20133.15
66988.44

36.55 (0.18%)
86.53 (0.13%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

66/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

1633.40

29-Nov-2023

Open
High
Low
Previous Close

1657.10
1679.75
1616.90
1644.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

175879
2874.49
1727.00
1227.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

27,669.93
42.72
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

26,578.62
1.96%
17.97

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
0.78
3.59

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
6.01
6.10

PAT CAGR (%)

10 Years
5 Years
3 Years

-
6.41
28.37

P:E (Median)

8 Years
5 Years
3 Years

60.63
52.88
39.23

P:BV (Average)

8 Years
5 Years
3 Years

13.68
14.10
15.41

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.63
29.99
27.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 953.38 905.61 5.27% 738.02 729.46 1.17% 782.16 791.92 -1.23% 799.11 807.98 -1.10%
Expenses 666.80 648.69 2.79% 596.77 581.53 2.62% 615.40 618.50 -0.50% 571.31 611.32 -6.54%
EBITDA 286.58 256.92 11.54% 141.25 147.93 -4.52% 166.76 173.42 -3.84% 227.80 196.66 15.83%
EBIDTM 30.06% 28.37% 19.14% 20.28% 21.32% 21.90% 28.51% 24.34%
Other Income 28.47 22.16 28.47% 36.80 27.79 32.42% 27.97 18.94 47.68% 23.60 10.50 124.76%
Interest 0.43 0.39 10.26% 0.28 0.68 -58.82% 0.65 0.27 140.74% 0.09 0.58 -84.48%
Depreciation 18.11 16.36 10.70% 16.36 15.82 3.41% 17.18 15.35 11.92% 16.41 17.87 -8.17%
PBT 296.51 262.33 13.03% 178.71 159.22 12.24% 187.30 206.24 -9.18% 223.53 170.79 30.88%
Tax 80.97 68.77 17.74% 48.13 43.59 10.42% 55.82 262.11 -78.70% 59.50 33.23 79.06%
PAT 215.54 193.56 11.36% 130.58 115.63 12.93% 131.48 -55.87 - 164.03 137.56 19.24%
PATM 22.61% 21.37% 17.69% 15.85% 16.81% -7.05% 20.53% 17.03%
EPS 12.72 11.43 11.29% 7.71 6.83 12.88% 7.76 -3.30 - 9.68 8.12 19.21%

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 956.99 916.87 4.38% 761.66 745.10 2.22% 787.45 809.63 -2.74% 802.30 815.92 -1.67%
Expenses 667.50 659.94 1.15% 617.78 596.18 3.62% 617.71 634.41 -2.63% 573.60 618.11 -7.20%
EBITDA 289.49 256.93 12.67% 143.88 148.92 -3.38% 169.74 175.22 -3.13% 228.70 197.81 15.62%
EBIDTM 30.25% 28.02% 18.89% 19.99% 21.56% 21.64% 28.51% 24.24%
Other Income 28.21 21.97 28.40% 36.44 27.61 31.98% 27.66 18.76 47.44% 23.42 10.32 126.94%
Interest 0.43 0.39 10.26% 0.28 0.68 -58.82% 0.65 0.28 132.14% 0.09 0.58 -84.48%
Depreciation 18.11 16.36 10.70% 16.36 15.82 3.41% 17.18 15.35 11.92% 16.41 17.87 -8.17%
PBT 299.16 262.15 14.12% 180.98 160.03 13.09% 189.97 207.85 -8.60% 224.25 171.76 30.56%
Tax 81.65 68.73 18.80% 48.73 43.80 11.26% 56.54 262.51 -78.46% 59.69 33.48 78.29%
PAT 217.51 193.42 12.45% 132.25 116.23 13.78% 133.43 -54.66 - 164.56 138.28 19.00%
PATM 22.73% 21.10% 17.36% 15.60% 16.94% -6.75% 20.51% 16.95%
EPS 12.84 11.42 12.43% 7.81 7.04 10.94% 7.88 71.96 -89.05% 9.71 8.87 9.47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Net Sales 3,272.67 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 Net Sales Growth 1.17% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% 2.72% -15.53% 29.13% Cost Of Goods Sold 1,250.67 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 Gross Profit 2,022.00 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 GP Margin 61.78% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% Total Expenditure 2,450.28 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 Power & Fuel Cost - 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 % Of Sales - 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% Employee Cost - 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 % Of Sales - 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% Manufacturing Exp. - 99.05 120.14 110.59 107.88 115.19 110.55 108.26 117.67 365.85 127.72 % Of Sales - 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% General & Admin Exp. - 189.33 143.99 117.27 164.31 178.51 203.43 194.72 154.34 177.98 134.79 % Of Sales - 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% Selling & Distn. Exp. - 180.97 199.59 124.73 212.36 202.81 154.38 178.88 164.26 222.32 186.27 % Of Sales - 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% Miscellaneous Exp. - 72.95 64.17 78.51 111.89 106.88 104.29 96.61 125.19 164.01 186.27 % Of Sales - 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% EBITDA 822.39 799.42 755.83 597.78 658.45 606.48 508.44 419.94 476.75 568.79 477.07 EBITDA Margin 25.13% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% Other Income 116.84 101.51 76.22 110.19 77.56 101.48 53.52 72.01 122.25 257.53 246.31 Interest 1.45 1.81 1.99 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 Depreciation 68.06 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 PBT 886.05 833.36 761.87 625.83 646.99 658.82 523.78 465.35 573.63 800.50 703.17 Tax 244.42 227.69 396.87 166.54 212.45 238.35 189.60 174.30 201.41 276.98 227.44 Tax Rate 27.59% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% PAT 641.63 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 PAT before Minority Interest 641.63 604.71 376.58 286.69 110.05 425.36 351.99 336.78 374.53 471.65 501.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.61% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% PAT Growth 64.15% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% -10.08% -20.59% -6.02% EPS 37.88 35.70 22.23 16.92 6.50 25.11 20.78 19.88 22.11 27.84 29.63

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Net Sales 3,308.40 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 Net Sales Growth 0.64% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% 2.49% -15.61% 28.96% Cost Of Goods Sold 1,283.43 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 Gross Profit 2,024.97 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 GP Margin 61.21% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% Total Expenditure 2,476.59 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 Power & Fuel Cost - 29.60 27.83 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 % Of Sales - 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% Employee Cost - 594.99 610.23 616.16 628.55 537.20 523.40 483.01 443.37 493.02 362.05 % Of Sales - 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% Manufacturing Exp. - 99.05 120.14 110.59 107.89 115.55 110.55 108.26 118.09 367.24 127.78 % Of Sales - 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% General & Admin Exp. - 189.33 144.08 117.31 164.51 178.60 204.45 195.08 154.85 178.21 135.34 % Of Sales - 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% 5.19% Selling & Distn. Exp. - 180.97 199.59 124.73 212.36 202.81 154.38 178.91 164.47 222.31 186.23 % Of Sales - 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% Miscellaneous Exp. - 68.62 58.09 75.74 112.58 107.20 105.12 98.67 127.99 168.72 186.23 % Of Sales - 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% 4.51% EBITDA 831.81 804.28 761.88 598.14 657.25 600.80 505.79 418.98 478.27 574.58 483.21 EBITDA Margin 25.14% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% Other Income 115.73 100.66 75.78 110.58 79.01 102.32 54.54 73.07 123.18 258.80 222.30 Interest 1.45 1.81 2.00 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 Depreciation 68.06 65.77 68.19 78.60 82.68 48.59 37.99 26.35 24.95 25.35 19.88 PBT 894.36 837.37 767.47 626.59 647.25 653.97 522.17 465.46 576.08 807.56 685.30 Tax 246.61 228.76 398.28 166.72 212.55 237.28 189.24 174.37 202.25 279.27 229.78 Tax Rate 27.57% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% PAT 647.75 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 PAT before Minority Interest 647.75 607.64 380.77 287.27 93.20 445.39 350.73 336.81 376.14 476.41 481.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.58% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% PAT Growth 64.71% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% -10.46% -21.05% -1.09% EPS 38.24 35.87 22.48 16.96 5.50 26.29 20.70 19.88 22.20 28.12 28.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Shareholder's Funds 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 Share Capital 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 Non-Current Liabilities 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 157.51 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 Long Term Provisions 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 241.04 Current Liabilities 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 883.07 Trade Payables 418.56 555.45 447.99 354.19 402.96 502.53 275.92 323.09 305.89 278.01 Other Current Liabilities 184.47 503.54 433.09 205.84 802.59 842.33 391.18 203.59 131.56 86.22 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 48.18 668.42 518.83 Total Liabilities 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 3,057.77 Net Block 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.06 100.07 Gross Block 649.79 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 319.19 299.08 Accumulated Depreciation 320.89 262.20 215.09 695.76 129.06 83.08 46.38 24.32 196.13 199.01 Non Current Assets 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 456.03 Capital Work in Progress 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 Non Current Investment 24.49 24.49 25.82 25.97 26.17 49.43 52.99 53.63 47.67 47.67 Long Term Loans & Adv. 347.22 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 232.87 Other Non Current Assets 5.84 5.44 7.03 7.17 7.84 4.75 6.47 0.06 11.12 13.55 Current Assets 2,466.72 3,670.60 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 2,601.73 Current Investments 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 Inventories 437.70 512.71 523.34 483.03 486.49 500.18 425.48 521.66 368.86 342.40 Sundry Debtors 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 Cash & Bank 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 Other Current Assets 167.62 79.55 218.22 48.43 1,578.61 1,585.33 332.19 121.90 197.99 125.80 Short Term Loans & Adv. 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 68.16 Net Current Assets 1,149.69 1,996.24 851.90 754.71 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 Total Assets 3,194.52 4,509.70 2,995.41 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48 3,057.76

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Shareholder's Funds 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 Share Capital 169.41 169.41 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 Non-Current Liabilities 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 Long Term Provisions 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 Current Liabilities 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 888.91 Trade Payables 427.79 579.33 466.13 357.06 405.81 505.86 278.93 327.74 308.04 285.63 Other Current Liabilities 184.59 503.74 450.11 222.85 802.71 842.35 390.47 202.82 130.09 84.13 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 253.08 668.42 519.15 Total Liabilities 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 3,037.23 Net Block 328.90 329.44 385.56 756.59 429.99 322.81 252.71 204.04 123.08 100.09 Gross Block 649.79 591.65 600.65 1,452.35 559.05 405.89 299.09 228.36 363.34 343.22 Accumulated Depreciation 320.89 262.20 215.09 695.76 129.06 83.08 46.38 24.32 240.26 243.13 Non Current Assets 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 Capital Work in Progress 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 Non Current Investment 0.00 0.00 1.35 1.49 1.69 1.84 5.40 6.04 0.06 0.06 Long Term Loans & Adv. 342.64 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 237.73 Other Non Current Assets 5.86 5.45 7.05 7.17 7.84 4.75 6.47 0.06 11.13 13.55 Current Assets 2,494.26 3,707.92 2,202.64 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 2,623.94 Current Investments 518.29 365.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 Inventories 459.97 534.70 546.70 483.03 486.49 500.18 425.80 525.87 375.58 346.97 Sundry Debtors 192.38 205.24 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 Cash & Bank 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 Other Current Assets 167.70 89.49 225.89 48.58 1,580.88 1,591.97 338.90 333.82 200.47 128.99 Short Term Loans & Adv. 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 310.58 112.04 71.19 Net Current Assets 1,167.89 2,009.49 848.06 752.93 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 Total Assets 3,193.03 4,520.02 3,011.52 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56 3,037.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Cash From Operating Activity 487.94 819.79 594.87 490.97 411.18 474.77 232.28 138.27 340.88 267.42 PBT 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 573.63 800.50 703.17 Adjustment -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 Changes in Working Capital -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 1.66 Cash after chg. in Working capital 757.61 968.00 760.11 704.78 620.71 676.33 390.46 353.51 597.94 524.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -260.57 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 -242.05 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -9.11 -36.06 -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 -14.97 Cash From Investing Activity 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 499.09 177.62 197.98 Net Fixed Assets -47.95 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 Net Investments -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 Others 1,005.84 -47.11 -551.19 -52.52 55.20 313.67 710.96 566.67 241.09 198.17 Cash from Financing Activity -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 Net Cash Inflow / Outflow -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 -24.68 Opening Cash & Equivalents 280.79 404.90 98.03 97.78 199.40 138.27 113.68 114.66 93.50 137.07 Closing Cash & Equivalent 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 115.01 112.39

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Cash From Operating Activity 484.23 810.75 577.91 490.50 409.49 472.80 234.37 138.90 337.64 281.31 PBT 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 576.08 807.56 685.30 Adjustment -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 Changes in Working Capital -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 -124.41 -36.90 11.45 Cash after chg. in Working capital 755.75 959.04 743.20 704.49 618.41 674.55 392.29 355.67 597.00 540.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -262.42 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 -244.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -9.11 -36.06 -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 0.00 Cash From Investing Activity 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 499.02 180.01 188.98 Net Fixed Assets -47.95 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 Net Investments -152.70 -364.26 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 Others 1,008.50 -32.96 -540.73 -46.26 56.19 316.49 708.52 566.60 243.48 189.17 Cash from Financing Activity -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 Net Cash Inflow / Outflow -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 -23.85 Opening Cash & Equivalents 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.30 94.93 137.67 Closing Cash & Equivalent 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 115.59 113.82

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Book Value (Rs.) 103.58 158.06 88.37 108.62 126.47 122.78 119.72 130.14 109.30 119.07 ROA 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% 16.56% ROE 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% ROCE 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% Fixed Asset Turnover 5.69 5.93 3.04 3.21 6.48 8.22 11.35 10.32 11.16 9.33 Receivable days 20.54 21.73 18.45 12.47 15.60 20.03 18.12 14.65 10.40 14.54 Inventory Days 49.10 53.51 58.87 54.87 57.56 58.34 57.72 57.50 37.61 42.77 Payable days 142.20 141.33 117.18 57.46 72.90 65.55 50.91 53.40 43.13 48.42 Cash Conversion Cycle -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 18.76 4.88 8.89 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13
Book Value (Rs.) 102.89 157.19 87.26 107.47 126.31 121.44 118.46 128.88 107.96 117.45 ROA 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% 15.95% ROE 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% ROCE 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% Fixed Asset Turnover 5.75 6.03 3.04 3.21 6.48 8.21 11.38 9.59 9.82 8.13 Receivable days 20.34 21.37 18.42 12.47 15.60 20.03 18.09 14.59 10.35 14.45 Inventory Days 50.87 54.91 60.14 54.88 57.56 58.36 57.89 57.97 38.01 43.02 Payable days 143.05 140.69 119.53 57.89 73.24 66.07 51.56 53.81 43.72 49.18 Cash Conversion Cycle -71.84 -64.41 -40.97 9.45 -0.07 12.32 24.42 18.75 4.64 8.28 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51

Top Investors:

lici money plus growth fund

icici prudential mnc fund

general insurance corporation of india

aditya birla sun life trustee private limited a/c

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
9th Nov 2023, 16:35 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback